Company / Profit Margin
Beam Therapeutics Inc. Profit Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-57.2%
FY2025
5-year range
-714.9% / -35.1%
FY2021-FY2025
Trend
+90.3%
vs FY2024
Sector context
#91 of 146
Health Care
What the data says
At -57.2%, Beam Therapeutics Inc.'s profit margin ranks #91 of 146 in the Health Care sector. Declined from -35.1% to -57.2% over the past 2 years.
Based on SEC 10-K filings.
-57.2% in FY2025 with a 5-year CAGR of +435087.2%.
Declined from -35.1% to -57.2% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +417.3pp
- 5-Year Change
- +435087.2pp
- 10-Year Change
- -
Sector benchmark
#91 of 146 in Health CareTop 62% of 146This company -57.2% Sector average -796.3%
▼
+92.8% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 90.3% year-over-year.
- Currently 739.0pp above the Health Care sector average.
- Peak profit margin was recorded in FY2023.
- Lowest profit margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -57.2% | +90.3% |
| FY2024 | -593.1% | -1590.3% |
| FY2023 | -35.1% | +92.6% |
| FY2022 | -474.5% | +33.6% |
| FY2021 | -714.9% | +99.8% |
| FY2020 | -435144.4% | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026